Corbus Pharmaceuticals Holdings (CRBP) Invested Capital (2021 - 2024)

Corbus Pharmaceuticals Holdings' Invested Capital history runs 4 years deep, the most recent figure standing at $10.7 million for Q2 2024.

• On a quarterly basis, Invested Capital fell 41.4% year-over-year to $10.7 million in Q2 2024; TTM through Mar 2025 was $10.7 million, a 83.43% decrease from a year earlier, with the FY2023 full-year figure at $15.9 million, down 15.29% from the prior year.
• Invested Capital slipped to $10.7 million in Q2 2024 per CRBP's latest filing, from $12.8 million in the prior quarter.
• Across five years, Invested Capital topped out at $19.3 million in Q3 2022 and bottomed at $10.7 million in Q2 2024.
• The 4-year median for Invested Capital is $18.7 million (2021), against an average of $17.2 million.
• Across the five-year window, Invested Capital increased 0.4% in 2023 and slumped 41.4% in 2024, its largest moves.
• Year by year, Invested Capital stood at $18.7 million in 2021, then gained by 0.27% to $18.8 million in 2022, then declined by 15.29% to $15.9 million in 2023, then tumbled by 32.46% to $10.7 million in 2024.
• Per Business Quant, the three latest CRBP Invested Capital figures stand at $10.7 million (Q2 2024), $12.8 million (Q1 2024), and $15.9 million (Q4 2023).